UK markets closed
  • FTSE 100

    7,901.80
    +81.64 (+1.04%)
     
  • FTSE 250

    20,593.46
    -21.24 (-0.10%)
     
  • AIM

    889.79
    +1.03 (+0.12%)
     
  • GBP/EUR

    1.1153
    -0.0052 (-0.46%)
     
  • GBP/USD

    1.2037
    -0.0192 (-1.57%)
     
  • BTC-GBP

    19,021.49
    -527.83 (-2.70%)
     
  • CMC Crypto 200

    535.42
    -1.43 (-0.27%)
     
  • S&P 500

    4,136.48
    -43.28 (-1.04%)
     
  • DOW

    33,926.01
    -127.89 (-0.38%)
     
  • CRUDE OIL

    73.23
    -0.16 (-0.22%)
     
  • GOLD FUTURES

    1,865.90
    +3.00 (+0.16%)
     
  • NIKKEI 225

    27,509.46
    +107.36 (+0.39%)
     
  • HANG SENG

    21,660.47
    -297.93 (-1.36%)
     
  • DAX

    15,476.43
    -32.77 (-0.21%)
     
  • CAC 40

    7,233.94
    +67.67 (+0.94%)
     

$31+ Billion Worldwide Contraceptives Industry to 2031 - Rising Frequency of STIs or Diseases is Driving Demand

Company Logo
Company Logo

Global Contraceptive Market

Global Contraceptive Market
Global Contraceptive Market

Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "Contraceptives Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global contraceptives market.

This report focuses on contraceptives market which is experiencing strong growth. The report gives a guide to the contraceptives market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

The global contraceptive market is expected to grow from $22.49 billion in 2021 to $24.07 billion in 2022 at a compound annual growth rate (CAGR) of 7.05%. The contraceptive market is expected to grow to $31.09 billion in 2026 at a compound annual growth rate (CAGR) of 6.60%.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.

  • Create regional and country strategies on the basis of local data and analysis.

  • Identify growth segments for investment.

  • Outperform competitors using forecast data and the drivers and trends shaping the market.

  • Understand customers based on the latest market research findings.

  • Benchmark performance against key competitors.

  • Utilize the relationships between key data sets for superior strategizing.

  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Major players in the contraceptives market are Merck & Co Inc, Cipla Inc, Church & Dwight Co Inc, Bayer AG, Reckitt Benckiser Group plc, Veru Inc, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Mithra Pharmaceuticals, Pfizer, Inc., Allergan Plc, Mankind Pharma, Karex Berhad, Piramal Enterprises Ltd, and Thai Nippon Rubber Industry Co Ltd.

The contraceptive market consists of sales of contraceptives by entities (organizations, sole traders, and partnerships) that refer to a drug or a device used to prevent pregnancy. Contraceptive drugs and devices are used to prevent pregnancy by keeping the egg and sperm apart, delaying the development of the egg, or preventing the combined sperm and egg (fertilized egg) from attaching to the uterine lining.

The main product types of contraceptives include oral contraceptive pills, topical contraceptives, injectables, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intra-uterine devices. Oral contraceptive pills are contraceptive tablets or birth control pills to prevent pregnancy. It includes hormones that prevent eggs from being released from the ovaries. The contraceptives are used by a wide range of age groups ranging from 15-24 years, 25-34 years, 35-44 years, and over 44 years. The contraceptives are distributed by clinics, hospitals, independent pharmacies, and other locations.

North America was the largest region in the contraceptives market in 2021 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rising frequency of sexually transmitted illnesses or diseases is driving the demand for contraceptives. Sexually transmitted diseases (STDs) are infections spread from one person to another through sexual interaction. The most typical contact occurs during anal, oral, and vaginal intercourse and they can spread through other close physical contact methods. Skin-to-skin contact is the most common reason for STDs such as herpes and HPV to spread. Contraceptives are used to control the spread of these diseases.

For instance, in 2020, the World Health Organization (WHO) estimated the occurrence of 374 million new sexually transmitted infections across the globe. Therefore, the increase in sexually transmitted illnesses or diseases is expected to boost the demand for contraceptives during the forecast period.

Technology advancement is a key trend gaining popularity in the contraceptive market. Digital Contraceptives are the latest trend in the contraceptives market. Digital Contraception is a way of tracking periods online to know which days are riskier for pregnancy.

In March 2021, Clue, a Berlin-based femtech company, received FDA approval to market Clue Birth Control, all-digital contraception based on period monitoring data. The birth control function can identify when days are high or low risk for pregnancy by integrating user menstrual cycle data with Clue's prediction algorithm. Users can then adjust their habits to fit their risk tolerance. Clue recommends that users refrain from sex entirely or use another form of contraception, such as condoms, on high-risk days.

The countries covered in the contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Report Attribute

Details

No. of Pages

175

Forecast Period

2022 - 2026

Estimated Market Value (USD) in 2022

$24.07 billion

Forecasted Market Value (USD) by 2026

$31.09 billion

Compound Annual Growth Rate

6.6%

Regions Covered

Global

Key Topics Covered:

1. Executive Summary

2. Contraceptives Market Characteristics

3. Contraceptives Market Trends And Strategies

4. Impact Of COVID-19 On Contraceptives

5. Contraceptives Market Size And Growth
5.1. Global Contraceptives Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Contraceptives Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Contraceptives Market Segmentation
6.1. Global Contraceptives Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Oral Contraceptive Pills

  • Topical Contraceptives

  • Injectables

  • Diaphragms

  • Vaginal Rings

  • Condoms

  • Contraceptive Sponges

  • Subdermal Implants

  • Intra-Uterine Devices

6.2. Global Contraceptives Market, Segmentation By Age Group, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15-24 Years
25-34 Years
35-44 Years
44 Years
6.3. Global Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Hospital Pharmacies

  • Independent Pharmacies

  • Online Pharmacies

  • Clinics

  • Others

7. Contraceptives Market Regional And Country Analysis
7.1. Global Contraceptives Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Contraceptives Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/8dpo7l

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900